JP2022546987A5 - - Google Patents
Info
- Publication number
- JP2022546987A5 JP2022546987A5 JP2022513603A JP2022513603A JP2022546987A5 JP 2022546987 A5 JP2022546987 A5 JP 2022546987A5 JP 2022513603 A JP2022513603 A JP 2022513603A JP 2022513603 A JP2022513603 A JP 2022513603A JP 2022546987 A5 JP2022546987 A5 JP 2022546987A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019103677 | 2019-08-30 | ||
| CNPCT/CN2019/103677 | 2019-08-30 | ||
| PCT/CN2020/112143 WO2021037212A1 (zh) | 2019-08-30 | 2020-08-28 | 用于对抗代谢疾病的组合物及其用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546987A JP2022546987A (ja) | 2022-11-10 |
| JP2022546987A5 true JP2022546987A5 (https=) | 2023-09-06 |
| JP7645244B2 JP7645244B2 (ja) | 2025-03-13 |
Family
ID=74683374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513603A Active JP7645244B2 (ja) | 2019-08-30 | 2020-08-28 | 代謝性疾患と闘うために使用される組成物およびその組成物の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220323408A1 (https=) |
| EP (1) | EP4023225B1 (https=) |
| JP (1) | JP7645244B2 (https=) |
| KR (1) | KR20220054351A (https=) |
| CN (1) | CN114364385B (https=) |
| CA (1) | CA3152868A1 (https=) |
| IL (1) | IL290927A (https=) |
| WO (1) | WO2021037212A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3163342A1 (en) * | 2019-12-05 | 2021-06-10 | Flagship Pioneering Innovations V, Inc. | Acylated active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease |
| CN116583274A (zh) * | 2020-12-14 | 2023-08-11 | 医学文库有限责任公司 | 用于治疗和预防微生物感染性疾病和相关炎性障碍的方法和药物组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5127093B1 (https=) | 1970-11-11 | 1976-08-10 | ||
| EP0177574B1 (en) | 1984-04-02 | 1989-12-20 | Cornell Research Foundation, Inc. | Aminocarnitines |
| HUT65327A (en) | 1992-06-11 | 1994-05-02 | Sandoz Ag | Process for producing phosphinyloxy-propyl-ammonium inner sact derwatives ang pharmateutical preparations containing them |
| IT1299266B1 (it) | 1998-05-15 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Inibitori reversibili della carnitina palmitoil trasferasi |
| US20110048980A1 (en) * | 2007-03-09 | 2011-03-03 | Symcopeia Company | Fatty Acid Oxidation Inhibitors Treating Hyperglycemia and Related Disorders |
| US20110275649A1 (en) * | 2010-05-05 | 2011-11-10 | Palmetto Pharmaceuticals Llc | Combination therapy for the prevention of statin induced diabetes |
| EP2654777A4 (en) * | 2010-12-21 | 2014-07-09 | Nestec Sa | METHOD AND COMPOSITIONS FOR ADMINISTERING THE BLOOD SUGAR IN ANIMALS |
-
2020
- 2020-08-28 JP JP2022513603A patent/JP7645244B2/ja active Active
- 2020-08-28 CA CA3152868A patent/CA3152868A1/en active Pending
- 2020-08-28 EP EP20856770.1A patent/EP4023225B1/en active Active
- 2020-08-28 KR KR1020227009807A patent/KR20220054351A/ko active Pending
- 2020-08-28 CN CN202080060415.1A patent/CN114364385B/zh active Active
- 2020-08-28 WO PCT/CN2020/112143 patent/WO2021037212A1/zh not_active Ceased
- 2020-08-28 US US17/639,181 patent/US20220323408A1/en active Pending
-
2022
- 2022-02-27 IL IL290927A patent/IL290927A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1993119B (zh) | 含他汀类药物和ω-3脂肪酸的组合物 | |
| CN100415224C (zh) | 包含脂肪酸和氨基酸的组合物 | |
| ES2380752T3 (es) | Agente profiláctico y/o terapéutico para hiperlipidemia | |
| JPWO2009151116A1 (ja) | 非アルコール性脂肪肝炎の予防／改善・治療薬 | |
| TW200836715A (en) | Novel composition for treating metabolic syndrome | |
| JP2011219496A (ja) | 高脂血症又はインスリン非依存性糖尿病の予防及び／又は治療のための医薬 | |
| RU2010135514A (ru) | Комбинации пероральных лекарственных средств, соединенных посредством оболочки | |
| JP2022546987A5 (https=) | ||
| EP3160458A1 (en) | Treatment of severe hypertriglyceridemia | |
| HUE026230T2 (en) | Pharmaceutical composition containing citrate and bicarbonate salts and use in the treatment of cystinuria | |
| IL274414B1 (en) | Oral rifamycin sv compositions | |
| JP2013216679A (ja) | 非アルコール性脂肪性肝炎の予防及び／又は治療のための医薬 | |
| JP5837877B2 (ja) | 静脈内投与イブプロフェンを用いた患者の治療 | |
| JP2020536098A (ja) | グリシン脳症を治療するためのベンゾエート含有組成物の使用 | |
| CN101686676A (zh) | 用于治疗糖尿病的方法和普罗布考衍生物的组合物 | |
| JP5063369B2 (ja) | メグリチニド類を含有する肝臓線維化予防用医薬組成物 | |
| TW200401636A (en) | Drug composition for blood sugar control | |
| UA81132C2 (en) | Combination of an antioxidant agent and a mixed or a selective ppar ligand for the and ? receptor sub-types for treating obesity | |
| AU2005209948B2 (en) | Use of aminosalicylates in diarrhoea-predominent Irritable Bowel Syndrome | |
| JP6454436B1 (ja) | ペマフィブラートを含有する医薬 | |
| JPS5998018A (ja) | 老化治療剤 | |
| WO2006006729A1 (ja) | Ｃ型肝炎ウイルス陽性ヒト肝硬変患者用肝癌発生・進展抑制剤 | |
| ES2267796T3 (es) | Uso de fibratos para la preparacion de un medicamento util en el tratamiento de insuficiencia cardiaca congestiva. | |
| CN110575447B (zh) | 一种用于防治糖尿病的药物组合物及其用途 | |
| JP2009179633A (ja) | 耐糖能異常用医薬組成物及び飲食品 |